WNCT

FDA Grants Priority Review for Addyi® (flibanserin) Paving the Way for Expanded Access to Treat Low Sexual Desire in Postmenopausal Women

Addyi is the first and only FDA-approved, hormone-free pill clinically proven to treat low sexual desire in women RALEIGH, N.C., July 24, 2025 /PRNewswire/ -- Sprout Pharmaceuticals today announced ...

‘Desire Doesn’t Expire’ After 50: What To Know About the Pink Pill (Exclusive)

Have you ever talked to your doctor about low libido and felt your concerns weren't taken seriously? Women over 50 are ...
Yahoo

Meet the Addyi Pill—a.k.a. Pink Viagra: Why the FDA's New 2025 Approval Is a ‘Historic First’ for Women Over 50

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...
KRQE Blogs

Unprecedented Abstract Highlights Addyi’s Remarkable Effects on Low Libido among Breast Cancer Patients

IRVINE, CA – July 5, 2023 – The Ad Firm is thrilled to announce the publication of an abstract by Sprout Pharmaceuticals, showcasing the remarkable effects of Addyi (flibanserin) on low libido among ...

The battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role

Sex, Drugs & Who Has Control” — premiering Friday on Paramount+ — explores the obstacles that Addyi overcame to securing FDA ...
AOL

FDA OKs Addyi, a Libido-Enhancing Drug for Women After Menopause

Addyi, sometimes referred to as “female Viagra,” is now approved for use to treat low sex drive in postmenopausal women. MoMo Productions/Getty Images The Food and Drug Administration (FDA) expanded ...